ABSTRACT
In June 2021, a task force commissioned by the Board of Directors of the Association for Professionals in Infection Prevention and Epidemiology (APIC) evaluated the landscape of health inequity and health disparities as they apply to infection prevention in health care settings. This task force, consisting of infection preventionists across the country, convened to evaluate current literature, identify relevant issues and make recommendations to the APIC Board of Directors for action steps to be taken.
Subject(s)
Advisory Committees , Infection Control , HumansABSTRACT
OBJECTIVE: Due to increased use of pre-exposure prohylaxis (PrEP) and its potential to affect HIV screening of blood donors, we undertook antiretroviral residual testing among HIV-negative male donors in England. METHODS: Residual plasma samples were obtainnd from 46 male donors confirmed positive for syphilis and 96 donors who were repeat reactive for HIV antibodies in screening but confirmed as HIV-negative by reference testing. These were tested for concentrations of tenofovir and emtricitabine by high-performance liquid chromatograhpy coupled with mass spectrometry. RESULTS: We found evidence of pre-exposure or post-exposure prophylaxis (PrEP/PEP) use in three male blood donors confirmed positive for syphilis (3 out of 46 screened, 6.5%). Two were estimated to have taken PrEP/PEP within a day of donating, and the third within 2 days. Two were new donors, whereas one had donated previously but acquired syphilis infection after his last donation. CONCLUSIONS: Our findings indicate that a small proportion of blood donors have not been disclosing PrEP/PEP use and therefore donating in non-compliance to donor eligibility criteria.
